Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80105919

Market status:

Not Marketed

Licence Status:

Active

Brand name(s):

Cold & Flu Formula

Licence holder:

New Roots Herbal Inc.

Dosage Form:

Capsule

Recommended route of administration:

Oral

Recommended use or purpose:

Andrographis paniculata helps reduce the severity and symptoms of the common cold. Used in Herbal Medicine to help maintain a healthy immune system. Source of fungal polysaccharides with immunomodulating properties.

Risk Information:

Cautions and Warnings 

If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you have an auto-immune disorder; if you are taking immunosuppressants; if you have a progressive systemic disease such as tuberculosis, leukosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection; if you have a kidney disorder, diabetes, or if you have blood pressure problems. If you are taking blood thinners, consult a health care practitioner prior to use. If you are taking prescription medications, consult a health care practitioner prior to use.

Contra-Indications 

Do not use if you are pregnant or breastfeeding.

Known Adverse Reactions 

Hypersensitivity (e.g. allergy) has been known to occur, in which case, discontinue use.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium	1.58 mg
Andrographis paniculata	200.0 mg	20 : 1 DHE: 4000 mg	30.0   % Andrographolide
Astragalus membranaceus	190.0 mg	16.0 : 1.0 DHE: 3040.0 mg Dry	3.0   % Astragaloside I
Commiphora myrrha	30.0 mg	7.0 : 1.0 DHE: 210.0 mg Dry
Echinacea purpurea	30.0 mg	6.0 : 1.0 DHE: 180.0 mg Dry	4.0   % Polyphenols
Ganoderma lucidum	10.0 mg	8.0 : 1.0 DHE: 80.0 mg Dry	40.0   % Polysaccharides
Grifola frondosa	10.0 mg	8.0 : 1.0 DHE: 80.0 mg Dry	40.0   % Polysaccharides
Lentinula edodes	10.0 mg	8.0 : 1.0 DHE: 80.0 mg Dry	40.0   % Polysaccharides
Rosmarinus officinalis	30.0 mg	10 : 1 DHE: 300 mg	5.0   % Carnosic acid
Sambucus nigra subsp. nigra	50.0 mg	50 : 1 DHE: 2500 mg	6.0   % Anthocyanosides

List of non-medicinal ingredients:

• Magnesium stearate
• Silicon dioxide

Date of licensing:

2020-11-05

Revised date of licence:

2023-09-01